Recos Updates JM Financial Forecasts 14.60 percent Upside for Dr. Reddys Laboratories , Sets Target Price at Rs - The Economic Times
| JM Stock | 176.60 5.10 2.97% |
Slightly above 55% of JM AB's private investors are presently thinking to get in. The analysis of current outlook of investing in JM AB suggests that some traders are interested regarding JM AB's prospects. JM AB's investing sentiment can be driven by a variety of factors including economic data, JM AB's earnings reports, geopolitical events, and overall market trends.
JM AB |
Recos Updates JM Financial Forecasts 14.60 percent Upside for Dr. Reddys Laboratories , Sets Target Price at Rs The Economic Times
Read at news.google.com
 |
JM AB Fundamental Analysis
We analyze JM AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JM AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JM AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
JM AB is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
JM AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JM AB stock to make a market-neutral strategy. Peer analysis of JM AB could also be used in its relative valuation, which is a method of valuing JM AB by comparing valuation metrics with similar companies.
Peers
JM AB Related Equities
| SINCH | Sinch AB | 1.36 | ||||
| NIBE-B | NIBE Industrier | 0.91 | ||||
| HTRO | Hexatronic Group | 0.30 | ||||
| THULE | Thule Group | 0.12 | ||||
| EVO | Evolution | 0.32 |
Additional Tools for JM AB Stock Analysis
When running JM AB's price analysis, check to measure JM AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JM AB is operating at the current time. Most of JM AB's value examination focuses on studying past and present price action to predict the probability of JM AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JM AB's price. Additionally, you may evaluate how the addition of JM AB to your portfolios can decrease your overall portfolio volatility.